Rep. Cathy McMorris Rodgers (R-WA) (Michael Brochstein/Sipa USA) (Sipa via AP Images)

May 25, 2023 03:03 PM EDTUpdated June 15, 11:37 AM

Mirroring Senate counterparts, House committee advances PBM reforms

Paul Schloesser

Associate Editor

The House Energy & Commerce Committee advanced multiple bills to the House floor in a seven-hour hearing Wednesday, some of which included measures to address …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Mirroring Senate counterparts, House committee advances PBM reforms

Paul Schloesser

Associate Editor

Sign up to read this article for free.

China’s biotech market is staging a comeback that US biotech can only wish for

Bristol Myers' schizophrenia drug fails Phase 3 trial for adjunctive treatment

Genentech vet launches ADC startup with $20M

With aims to become a 'generational biotech,' Zealand Pharma hires Lilly veteran as science chief

Ascletis posts puzzling Phase 1 update on obesity pill

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Mir­ror­ing Sen­ate coun­ter­parts, House com­mit­tee ad­vances PBM re­forms

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Chi­na’s biotech mar­ket is stag­ing a come­back that US biotech can on­ly wish for

Bris­tol My­er­s' schiz­o­phre­nia drug fails Phase 3 tri­al for ad­junc­tive treat­ment

Genen­tech vet launch­es ADC start­up with $20M

With aims to be­come a 'gen­er­a­tional biotech,' Zealand Phar­ma hires Lil­ly vet­er­an as sci­ence chief

As­cle­tis posts puz­zling Phase 1 up­date on obe­si­ty pill

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

Mirroring Senate counterparts, House committee advances PBM reforms

China’s biotech market is staging a comeback that US biotech can only wish for

Bristol Myers' schizophrenia drug fails Phase 3 trial for adjunctive treatment

Genentech vet launches ADC startup with $20M

With aims to become a 'generational biotech,' Zealand Pharma hires Lilly veteran as science chief

Ascletis posts puzzling Phase 1 update on obesity pill

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence